The immunopathology of multiple sclerosis: an overview, Brain Pathol, vol.17, pp.210-218, 2007. ,
Treatment decisions in multiple sclerosis-insights from real-world observational studies, Nat Rev Neurol, 2017. ,
, Int MS J, vol.14, pp.5-10, 2007.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis, Brain, vol.138, pp.1863-74, 2015. ,
Defining the clinical course of multiple sclerosis: the 2013 revisions, Neurology, vol.83, pp.278-86, 2014. ,
Will the real multiple sclerosis please stand up?, Nat Rev Neurosci, vol.13, pp.507-521, 2012. ,
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals, Neurology, vol.60, pp.640-646, 2003. ,
Intracranial gadolinium deposition after contrast-enhanced MR imaging, Radiology, vol.275, pp.772-82, 2015. ,
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury, J Neuropathol Exp Neurol, vol.67, pp.1137-1185, 2008. ,
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis, J Biol Chem, vol.272, pp.32401-32411, 1997. ,
The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation, Biochem J, vol.371, pp.395-403, 2003. ,
TWEAK is expressed at the cell surface of monocytes during multiple sclerosis, J Leukoc Biol, vol.85, pp.132-137, 2009. ,
TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity, J Neuroimmunol, vol.133, pp.116-139, 2002. ,
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis, Clin Immunol, vol.117, pp.15-23, 2005. ,
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier, J Neuroinflammation, vol.10, p.9, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00787290
Acute axonal injury in multiple sclerosis correlation with demyelination and inflammation, Brain, vol.123, pp.1174-83, 2000. ,
Axonal transection in the lesions of multiple sclerosis, N Engl J Med, vol.338, pp.278-85, 1998. ,
Ultrasmall superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome, Mult Scler J, vol.22, issue.8, pp.1032-1041, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02457660
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol, vol.69, pp.292-302, 2011. ,
17:51 ? fast, convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over, J Transl Med, 2019. ,
, Ready to submit your research ? Choose BMC and benefit from
Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS), Neurology, vol.33, pp.1444-52, 1983. ,
New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann Neurol, vol.13, pp.227-258, 1983. ,
Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases?, Front Immunol, vol.4, p.489, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01718196
TWEAK induces angiogenesis and proliferation of endothelial cells, J Biol Chem, vol.274, pp.8455-8464, 1999. ,
Dual role for TWEAK in angiogenic regulation, J Cell Sci, vol.115, pp.267-74, 2002. ,
TWEAK stimulation of astrocytes and the proinflammatory consequences, Glia, vol.32, pp.102-109, 2000. ,
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies, Arthritis Res, vol.4, pp.126-159, 2002. ,
TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages, Circ J Off J Jpn Circ Soc, vol.68, pp.396-405, 2004. ,
TWEAK is a novel arthritogenic mediator, J Immunol, vol.177, pp.2610-2630, 2006. ,
TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease, Cytokine, vol.40, pp.1-16, 2007. ,
Mechanisms of macrophage recruitment in Wallerian degeneration, Acta Neuropathol, vol.89, pp.363-370, 1995. ,
,
, Monocyte/macrophage differentiation in early multiple sclerosis lesions, Ann Neurol, vol.38, pp.788-96, 1995.
TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia, J Cereb Blood Flow Metab, vol.27, pp.534-578, 2007. ,
Neuropsychiatric lupus, the blood brain barrier, and the TWEAK/Fn14 pathway, Front Immunol, vol.4, p.484, 2013. ,
Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway, J Autoimmun, vol.43, pp.44-54, 2013. ,
Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning-a comparison of methods, Magn Reson Med, vol.24, pp.174-180, 1992. ,
Blood-CSF barrier integrity in multiple sclerosis, Acta Neurol Scand, vol.94, pp.404-414, 1996. ,
Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss, Glia, vol.48, pp.1-13, 2004. ,
Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation, J Neurosci, vol.25, pp.10094-100, 2005. ,
Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models, Brain Pathol, vol.23, pp.34-44, 2013. ,
Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig, Magn Reson Med, vol.30, pp.326-357, 1993. ,
Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study, J Neuropathol Exp Neurol, vol.53, pp.625-661, 1994. ,
Association between pathological and MRI findings in multiple sclerosis, Lancet Neurol, vol.11, pp.349-60, 2012. ,
Pathological mechanisms in progressive multiple sclerosis, Lancet Neurol, vol.14, pp.183-93, 2015. ,
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis, Ann Neurol, vol.43, pp.499-506, 1998. ,
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain, Ann Neurol, vol.56, pp.407-422, 2004. ,